Invitae Corp NVTA:NYSE

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 9:04 AM EDT
2.43quote price arrow down-0.01 (-0.41%)
Volume
105,794
Close
2.44quote price arrow down-0.12 (-4.69%)
Volume
5,937,459
52 week range
1.83 - 30.28
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close2.44
  • 52 Week High30.28
  • 52 Week High Date09/27/21
  • 52 Week Low1.83
  • 52 Week Low Date07/28/22

Key Stats

  • Market Cap574.06M
  • Shares Out235.27M
  • 10 Day Average Volume9.95M
  • Dividend-
  • Dividend Yield-
  • Beta1.62
  • YTD % Change-84.02

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close2.44
  • 52 Week High30.28
  • 52 Week High Date09/27/21
  • 52 Week Low1.83
  • 52 Week Low Date07/28/22
  • Market Cap574.06M
  • Shares Out235.27M
  • 10 Day Average Volume9.95M
  • Dividend-
  • Dividend Yield-
  • Beta1.62
  • YTD % Change-84.02

RATIOS/PROFITABILITY

  • EPS (TTM)-13.48
  • P/E (TTM)-0.18
  • Fwd P/E (NTM)-1.20
  • EBITDA (TTM)-714.129M
  • ROE (TTM)-204.52%
  • Revenue (TTM)500.83M
  • Gross Margin (TTM)21.87%
  • Net Margin (TTM)-620.69%
  • Debt To Equity (MRQ)413.82%

EVENTS

  • Earnings Date11/07/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Invitae Corp

 

Profile

MORE
Invitae Corporation is a medical genetics company. The Company is engaged in delivering genetic testing services that support a lifetime of patient care from inherited disease diagnoses, to family planning, to proactive health screening to personalized diagnosis, treatment and monitoring of cancer. These tests are delivered through a platform that serves patients, healthcare providers, biopharma companies and other partners, thereby capturing the potential of genetics and...
Randal Scott Ph.D.
Chairman of the Board
Kenneth Knight
Chief Executive Officer
Yafei Wen
Chief Financial Officer
Robert Werner
Chief Accounting Officer
Address
1400 16Th Street
San Francisco, CA
94103
United States

Top Peers

SYMBOLLASTCHG%CHG
ITOS
Iteos Therapeutics Inc
19.09-0.03-0.16%
RGNX
Regenxbio Inc
22.86-0.67-2.85%
AGEN
Agenus Inc
2.13-0.11-4.91%
ICPT
Intercept Pharmaceuticals Inc
15.24UNCHUNCH
HLTH
Cue Health Inc
3.04-0.14-4.40%